Home > Insider Trading > Filing (0000899243-20-020566)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1693011	Inozyme Pharma Inc.	INZY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551966	Lorne Robert Hopfner	C/O Inozyme Pharma, Inc. 321 Summer Street, Suite 400 Boston MA 02210		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-28	1,403,654	$0.00	1,403,654	No	4	C	Indirect	By Pivotal bioVenture Partners Fund I, L.P.
Common Stock	Acquisiton	2020-07-28	187,500	$16.00	1,591,154	No	4	P	Indirect	By Pivotal bioVenture Partners Fund I, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Pivotal bioVenture Partners Fund I, L.P.
No	4	P	Indirect	By Pivotal bioVenture Partners Fund I, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-07-28	10,489,510	$0.00	1,403,654	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The shares are held of record by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P. ("Pivotal GP"). The general partner of Pivotal GP is Pivotal bioVenture Partners Fund I U.G.P., Ltd. Robert Hopfner, Vincent Cheung, Peter Bisgaard, and Heather Preston are managing partners of Pivotal's investment advisor and may be deemed to have shared voting and dispositive power over the shares owned by Pivotal. Dr. Hopfner disclaims beneficial ownership over such shares except to the extent of any pecuniary interest therein.